XERS icon

Xeris Biopharma Holdings
XERS

Overview Fund Activity

143 hedge funds and large institutions have $182M invested in Xeris Biopharma Holdings in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 14 closing their positions.

Holders
143
Holders Change
+9
Holders Change %
+6.72%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
48
Reduced
34
Closed
14
Calls
$1.26M
Puts
$340K
Net Calls
+$922K
Net Calls Change
+$192K

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$6.23M
2
CP
2
CenterBook Partners
Connecticut
$9.92M
3
Walleye Capital
3
Walleye Capital
New York
$3.2M
4
Morgan Stanley
4
Morgan Stanley
New York
$6.71M
5
KCM
5
Kennedy Capital Management
Missouri
$1.72M

Top Sellers

1
MB
1
MPM BioImpact
Massachusetts
$0
2
GCP
2
GSA Capital Partners
United Kingdom
$78K
3
ICM
3
Invenomic Capital Management
Massachusetts
$0
4
Lazard Asset Management
4
Lazard Asset Management
New York
$1.08M
5
Millennium Management
5
Millennium Management
New York
$4.12M
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
151
Two Sigma Investments
New York
– -$60.3K -26,803 Closed
Two Sigma Advisers
152
Two Sigma Advisers
New York
– -$53K -23,559 Closed
TSS
153
Two Sigma Securities
New York
– -$29K -12,900 Closed
SW
154
Simplicity Wealth
New Jersey
– -$27.4K -12,156 Closed
TC
155
TownSquare Capital
Utah
– -$25.4K -11,267 Closed
National Bank of Canada
156
National Bank of Canada
Quebec, Canada
– -$4.1K -1,890 Closed
ACM
157
ADAR1 Capital Management
Texas
– -$2.25K -1,000 Closed
3 4 5 6
7